Biomarker Analysis in CLEOPATRA: Searching for a Sensitive Prognostic Factor in Breast Cancer

被引：11

作者：

Avan, Amir ^{[1
]}

Avan, Abolfazl ^{[2
]}

Maftouh, Mina ^{[3
]}

Mobarhan, Majid Ghayour ^{[1
,4
]}

Shahidsales, Soudabeh ^{[5
]}

Gholamin, Sharareh ^{[6
]}

机构：

[1] Mashhad Univ Med Sci, Sch Med, Mashhad, Iran

[2] Mashhad Univ Med Sci, Mashhad, Iran

[3] Mashhad Univ Med Sci, Sch Med, Canc Res Ctr, Mashhad, Iran

[4] Brighton & Sussex Med Sch, Brighton, E Sussex, England

[5] Mashhad Univ Med Sci, Canc Res Ctr, Mashhad, Iran

[6] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期

关键词：

D O I：

10.1200/JCO.2014.60.4702

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：1711 / +

页数：3

共 8 条

[1]

Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories [J].

Baehner, Frederick L. ;

Achacoso, Ninah ;

Maddala, Tara ;

Shak, Steve ;

Quesenberry, Charles P., Jr. ;

Goldstein, Lynn C. ;

Gown, Allen M. ;

Habel, Laurel A. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (28) :4300-4306

[2]

Biomarker Analyses in CLEOPATRA: A Phase III, Placebo-Controlled Study of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive, First-Line Metastatic Breast Cancer [J].

Baselga, Jose ;

Cortes, Javier ;

Im, Seock-Ah ;

Clark, Emma ;

Ross, Graham ;

Kiermaier, Astrid ;

Swain, Sandra M. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (33) :3753-+

[3]

Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin α2 as a potential novel prognostic marker in breast cancer [J].

Dahl, Edgar ;

Kristiansen, Glen ;

Gottlob, Kathrin ;

Klaman, Irina ;

Ebner, Elke ;

Hinzmann, Bernd ;

Hermann, Klaus ;

Pilarsky, Christian ;

Duerst, Matthias ;

Klinkhammer-Schalke, Monika ;

Blaszyk, Hagen ;

Knuechel, Ruth ;

Hartmann, Arndt ;

Rosenthal, Andre ;

Wild, Peter J. .

CLINICAL CANCER RESEARCH, 2006, 12 (13) :3950-3960

[4]

Treatment tailoring based on molecular characterizations [J].

Dinh, P. ;

Sotiriou, C. .

ANNALS OF ONCOLOGY, 2008, 19 :46-50

[5]

Layfield Lester J, 2003, Breast J, V9, P257, DOI 10.1046/j.1524-4741.2003.09325.x

[6]

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. [J].

Slamon, DJ ;

Leyland-Jones, B ;

Shak, S ;

Fuchs, H ;

Paton, V ;

Bajamonde, A ;

Fleming, T ;

Eiermann, W ;

Wolter, J ;

Pegram, M ;

Baselga, J ;

Norton, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :783-792

[7]

Opinion - Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? [J].

Sotiriou, Christos ;

Piccart, Martine J. .

NATURE REVIEWS CANCER, 2007, 7 (07) :545-553

[8]

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes [J].

Vandesompele, Jo ;

De Preter, Katleen ;

Pattyn, Filip ;

Poppe, Bruce ;

Van Roy, Nadine ;

De Paepe, Anne ;

Speleman, Frank .

GENOME BIOLOGY, 2002, 3 (07)

← 1 →